Now that their role in vaccine research is over, 117 chimpanzees in Japan
face an uncertain fate. The chimps were imported in 1975 for a hepatitis B
vaccine programme and are now in a holding facility run by the drug company
Sanwa Kagaku. The company says it can no longer afford the annual £1.5
million upkeep. There are only a few comparable chimp facilities in the world,
and all are government-subsidised. But the Japanese government is reluctant to
take responsibility for the chimps.
More from New Scientist
Explore the latest news, articles and features
Technology
Test moderators use AI-generated writing to judge literacy standards
News
Mind
THC in cannabis may reduce nightmares in people with PTSD
News
Environment
Fishers detonate a bomb every hour on one Indonesian coral reef
News
Environment
How bad is the UK drought and how long will it continue?
News
Popular articles
Trending New Scientist articles